1. Home
  2. SINT vs BIVI Comparison

SINT vs BIVI Comparison

Compare SINT & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

N/A

Current Price

$2.13

Market Cap

10.9M

Sector

Health Care

ML Signal

N/A

Logo BioVie Inc.

BIVI

BioVie Inc.

N/A

Current Price

$1.47

Market Cap

10.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SINT
BIVI
Founded
1996
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
10.3M
IPO Year
2007
2013

Fundamental Metrics

Financial Performance
Metric
SINT
BIVI
Price
$2.13
$1.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
★ $9.13
$5.26
AVG Volume (30 Days)
29.4K
★ 283.6K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
★ 74.83
EPS
★ N/A
N/A
Revenue
★ $1,018,000.00
N/A
Revenue This Year
$190.28
N/A
Revenue Next Year
$79.38
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.40
$0.82
52 Week High
$4.64
$3.79

Technical Indicators

Market Signals
Indicator
SINT
BIVI
Relative Strength Index (RSI) 66.00 40.85
Support Level $1.83 $1.18
Resistance Level $2.46 $1.76
Average True Range (ATR) 0.16 0.13
MACD 0.04 -0.04
Stochastic Oscillator 64.20 5.65

Price Performance

Historical Comparison
SINT
BIVI

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: